trulieve cannabis corp - TCNNF

TCNNF

Close Chg Chg %
5.97 0.24 4.02%

Pre-Market

6.21

+0.24 (4.02%)

Volume: 200.31K

Last Updated:

Dec 4, 2025, 3:58 PM EDT

Company Overview: trulieve cannabis corp - TCNNF

TCNNF Key Data

Open

$5.63

Day Range

5.63 - 6.30

52 Week Range

3.02 - 9.95

Market Cap

$1.14B

Shares Outstanding

191.16M

Public Float

160.68M

Beta

1.16

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$0.70

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

1.09M

 

TCNNF Performance

1 Week
 
10.76%
 
1 Month
 
-8.85%
 
3 Months
 
-21.24%
 
1 Year
 
8.94%
 
5 Years
 
-80.34%
 

TCNNF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 9
Full Ratings ➔

About trulieve cannabis corp - TCNNF

Trulieve Cannabis Corp. engages in the provision of medical cannabis products and services. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Quincy, FL.

TCNNF At a Glance

Trulieve Cannabis Corp.
6749 Ben Bostic Road
Quincy, Florida 32351
Phone 1-850-480-7955 Revenue 1.19B
Industry Agricultural Commodities/Milling Net Income -155,105,000.00
Sector Process Industries 2024 Sales Growth 5.074%
Fiscal Year-end 12 / 2025 Employees 6,000
View SEC Filings

TCNNF Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.834
Price to Book Ratio 0.789
Price to Cash Flow Ratio 3.64
Enterprise Value to EBITDA 5.706
Enterprise Value to Sales 1.266
Total Debt to Enterprise Value 0.549

TCNNF Efficiency

Revenue/Employee 197,748.333
Income Per Employee -25,850.833
Receivables Turnover 51.481
Total Asset Turnover 0.416

TCNNF Liquidity

Current Ratio 4.365
Quick Ratio 2.695
Cash Ratio 2.167

TCNNF Profitability

Gross Margin 50.817
Operating Margin 7.188
Pretax Margin 3.60
Net Margin -13.073
Return on Assets -5.237
Return on Equity -11.167
Return on Total Capital -7.163
Return on Invested Capital -7.702

TCNNF Capital Structure

Total Debt to Total Equity 65.366
Total Debt to Total Capital 39.528
Total Debt to Total Assets 28.127
Long-Term Debt to Equity 63.226
Long-Term Debt to Total Capital 38.234
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Trulieve Cannabis Corp - TCNNF

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
938.39M 1.24B 1.13B 1.19B
Sales Growth
+79.93% +32.12% -8.92% +5.07%
Cost of Goods Sold (COGS) incl D&A
420.35M 677.19M 650.39M 583.55M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
78.22M 185.57M 166.85M 177.89M
Depreciation
48.42M 87.65M 86.45M 95.66M
Amortization of Intangibles
29.80M 97.92M 80.40M 82.23M
COGS Growth
+184.57% +61.10% -3.96% -10.28%
Gross Income
518.03M 562.62M 478.80M 602.94M
Gross Income Growth
+38.58% +8.61% -14.90% +25.93%
Gross Profit Margin
+55.20% +45.38% +42.40% +50.82%
2021 2022 2023 2024 5-year trend
SG&A Expense
315.72M 454.67M 386.16M 517.65M
Research & Development
- - - -
-
Other SG&A
315.72M 454.67M 386.16M 517.65M
SGA Growth
+103.10% +44.01% -15.07% +34.05%
Other Operating Expense
- - - -
-
Unusual Expense
5.16M 72.90M 304.37M (5.29M)
EBIT after Unusual Expense
197.15M 35.05M (211.72M) 90.58M
Non Operating Income/Expense
1.14M 1.38M 8.76M 14.33M
Non-Operating Interest Income
- 1.30M 6.16M 14.68M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
34.79M 79.77M 81.57M 62.19M
Interest Expense Growth
+71.90% +129.31% +2.25% -23.75%
Gross Interest Expense
34.79M 84.47M 81.72M 63.27M
Interest Capitalized
- 4.70M 148.00K 1.08M
Pretax Income
163.51M (43.35M) (284.54M) 42.71M
Pretax Income Growth
+3.85% -126.51% -556.45% +115.01%
Pretax Margin
+17.42% -3.50% -25.20% +3.60%
Income Tax
146.06M 161.82M 151.36M 197.59M
Income Tax - Current - Domestic
172.32M 228.68M 171.49M 207.96M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(26.26M) (18.35M) (18.94M) (10.37M)
Income Tax - Deferred - Foreign
- - (48.51M) (1.19M)
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
17.45M (205.17M) (435.90M) (154.88M)
Minority Interest Expense
(587.00K) (6.66M) (5.15M) (5.47M)
Net Income
18.03M (198.50M) (430.75M) (149.40M)
Net Income Growth
-71.38% -1,200.83% -117.00% +65.32%
Net Margin Growth
+1.92% -16.01% -38.15% -12.59%
Extraordinaries & Discontinued Operations
- (47.56M) (96.05M) (5.70M)
Discontinued Operations
- (47.56M) (96.05M) (5.70M)
Net Income After Extraordinaries
18.03M (246.06M) (526.80M) (155.11M)
Preferred Dividends
- - - -
-
Net Income Available to Common
18.03M (246.06M) (526.80M) (155.11M)
EPS (Basic)
0.1294 -1.3089 -2.7877 -0.8164
EPS (Basic) Growth
-76.67% -1,111.51% -112.98% +70.71%
Basic Shares Outstanding
139.37M 188.00M 188.97M 189.99M
EPS (Diluted)
0.1229 -1.3089 -2.7877 -0.8164
EPS (Diluted) Growth
-76.92% -1,165.01% -112.98% +70.71%
Diluted Shares Outstanding
146.76M 188.00M 188.97M 189.99M
EBITDA
280.54M 293.52M 259.49M 263.18M
EBITDA Growth
+12.87% +4.63% -11.59% +1.42%
EBITDA Margin
+29.90% +23.67% +22.98% +22.18%

Snapshot

Average Recommendation BUY Average Target Price 14.919
Number of Ratings 9 Current Quarters Estimate -0.035
FY Report Date 12 / 2025 Current Year's Estimate -0.393
Last Quarter’s Earnings -0.14 Median PE on CY Estimate N/A
Year Ago Earnings -0.82 Next Fiscal Year Estimate -0.036
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 4 3 7 7
Mean Estimate -0.04 -0.03 -0.39 -0.04
High Estimates -0.01 0.01 -0.33 0.11
Low Estimate -0.07 -0.08 -0.43 -0.27
Coefficient of Variance -71.90 -152.51 -8.41 -348.55

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 8 8 8
OVERWEIGHT 1 1 1
HOLD 0 0 0
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Trulieve Cannabis Corp in the News